Our Commitment

Every day, more than 500 researchers and staff come to work at Intellia. We are motivated by our mission to develop potentially curative genome editing treatments for people living with severe diseases.

John Leonard, M.D.
Intellia’s President & CEO

John Leonard, M.D.
Intellia’s President & CEO

“Many of us pursuing work in the biotechnology industry are inspired by the loss of a loved one or someone in our community who is living with a disease.”